#$%^&*AU2018200449A120180208.pdf#####ABSTRACT The present invention describes combination treatment comprising a PD-I axis binding antagonist, chemotherapy and optionally a VEGF antagonist and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer. 9786917_1 (GHMatters) P98670.AU.1